Rap2b is known to modulate different aspects of cancer cells, such as cell adhesion, proliferation, migration, and invasion, through various signaling pathways, including PTEN/PI3K/AKT/ERK1/2, P53/PLC, and EGF/PLC/Src [7, 46–48]. Here, SRC is linked to cancer.